| abstract |
The present invention provides methods and pharmaceutical compositions comprising a peptide sequence of endogenous angiotensin I or biologically active fragments thereof in combination with an antigen or immunogenic portion of an antigen for inducing a robust cytotoxic T lymphocyte response and maintaining an ongoing antigen-specific cytotoxic T lymphocyte memory, and their uses for treating or preventing pathogenic diseases. |